Literature DB >> 11915940

The murine complement regulator Crry: new insights into the immunobiology of complement regulation.

H Molina1.   

Abstract

Complement has an important role in inflammation and in the normal function of the immune system. Activated complement fragments have the capacity to bind and damage self-tissues. Cells from vertebrates express on their surface regulators of complement activation that protect them from the deleterious effects of cell-bound complement fragments. Abnormalities in these regulators of complement activation may participate in the pathogenesis of autoimmune diseases and inflammatory disorders. Murine Crry is one of these regulators that inhibits the activation of the third component of complement and protects self-tissues from complement-mediated damage. Experimental work on Crry has increased our understanding of the immunobiology of complement regulation and the potential role of complement and complement inhibitors in the development and treatment of human diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11915940     DOI: 10.1007/s00018-002-8418-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  14 in total

1.  CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent.

Authors:  Keith M Woods; Michael R Pope; Sara M Hoffman; Sherry D Fleming
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

2.  Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.

Authors:  Alejandra Bosco; Sarah R Anderson; Kevin T Breen; Cesar O Romero; Michael R Steele; Vince A Chiodo; Sanford L Boye; William W Hauswirth; Stephen Tomlinson; Monica L Vetter
Journal:  Mol Ther       Date:  2018-08-24       Impact factor: 11.454

Review 3.  Emerging roles and new functions of CD46.

Authors:  M Kathryn Liszewski; Claudia Kemper; Jeffrey D Price; John P Atkinson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

Review 4.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

5.  Antibody-mediated retinal pericyte injury: implications for diabetic retinopathy.

Authors:  Yan Li; Dawn Smith; Qing Li; Nader Sheibani; Suber Huang; Timothy Kern; Ram H Nagaraj; Feng Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-13       Impact factor: 4.799

6.  An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.

Authors:  Svetlana N Tchepeleva; Joshua M Thurman; Katherine Ruff; Stephen J Perkins; Laurence Morel; Susan A Boackle
Journal:  J Immunol       Date:  2010-07-21       Impact factor: 5.422

7.  Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model.

Authors:  Elaine C Johnson; Lijun Jia; William O Cepurna; Thomas A Doser; John C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

8.  Complement-dependent T-cell lymphopenia caused by thymocyte deletion of the membrane complement regulator Crry.

Authors:  Takashi Miwa; Lin Zhou; Yuko Kimura; David Kim; Avinash Bhandoola; Wen-Chao Song
Journal:  Blood       Date:  2009-01-09       Impact factor: 22.113

9.  Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack.

Authors:  Lidia Barata; Takashi Miwa; Sayaka Sato; David Kim; Imran Mohammed; Wen-Chao Song
Journal:  J Immunol       Date:  2013-02-06       Impact factor: 5.422

10.  Genome-wide association studies of 74 plasma metabolites of German shepherd dogs reveal two metabolites associated with genes encoding their enzymes.

Authors:  Pamela Xing Yi Soh; Juliana Maria Marin Cely; Sally-Anne Mortlock; Christopher James Jara; Rachel Booth; Siria Natera; Ute Roessner; Ben Crossett; Stuart Cordwell; Mehar Singh Khatkar; Peter Williamson
Journal:  Metabolomics       Date:  2019-09-06       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.